NET LOSS PER SHARE (Details) - Schedule of Potentially Dilutive Equity Instruments - shares	Dec. 31, 2019	Dec. 31, 2018
Schedule of Potentially Dilutive Equity Instruments [Abstract]
Stock options	12,833,780	10,073,380
Warrants	11,773,214	6,217,214
Accrued stock payable	42,736
Possibly dilutive equity instruments	24,649,730	16,290,594

Number of options outstanding, including both vested and non-vested options.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant